Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Hadrup BioMed Holding ApS
APS
Active
CVR 38034871
Kirkebakken 12
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2016
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -57K
+82% vs 2023
EBITDA margin
100.0%
-82% vs 2023
Equity ratio
99.0%
Financial strength
Net profit 2024
DKK 190K
+89% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -57K
+82%
EBITDA
DKK -57K
-82%
Net profit
DKK 190K
+89%
Total assets
DKK 2,6M
-64%
Equity
DKK 2,6M
-64%
Employees
—
—
Company information
Legal name
Hadrup BioMed Holding ApS
CVR number
38034871
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
26. september 2016
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive virksomhed i medico- og biotekbranchen og hermed forbundet virksomhed
Contact
Address
Kirkebakken 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Lyngby-Taarbæk
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-22
-24
-10
-31
-57
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-22
-24
-10
-31
-57
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-22
-24
-10
-31
-57
Net financials
-0
7.080
5.927
154
255
Profit before tax
-23
7.108
5.917
123
198
Tax
-0
-0
-50
22
7
Net profit
-23
7.108
5.967
101
190
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
100
2.008
7.587
7.153
2.584
Equity
-13
1.896
7.462
7.063
2.558
Long-term debt
0
0
0
0
0
Short-term debt
113
112
125
90
26
Total debt
113
112
125
90
26
Financial ratios
5-year trend
EBITDA margin
-5695900.0%
This company
15.8%
Market median
-36050100% vs market
2020
2024
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
2020
2024
Return on equity
7.4%
This company
18.4%
Market median
-60% vs market
2020
2024
Net profit margin
19030600.0%
This company
8.1%
Market median
+234945579% vs market
2020
2024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
2020
2024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
LH
Lis Hanne Reker
Management
Management
2023 – 2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Sine Hadrup
Individual
100%
100%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Hadrup BioMed Holding ApS
(this company)
p.A.c. ApS
Immumap Services ApS
Board network connections
Board members of Hadrup BioMed Holding ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Lis Hanne Reker
Management
0 companies